Business Description
Apnimed is a pharmaceutical company focused on creating pill-based treatments for breathing disorders that occur during sleep. Its lead product, AD109, works by correcting the muscle and nerve dysfunction that causes obstructive sleep apnea, offering patients an alternative to traditional mechanical devices. Founded in 2017 and based in Cambridge, Massachusetts, the company aims to serve patients worldwide.
